The FDA’s refusal to review marketing plans was error and not harmless (disagreeing with Fifth and DC Circuits).Read More
Tags :PMTA
The FDA’s refusal to review marketing plans was error and not harmless (disagreeing with Fifth and DC Circuits).Read More
Despite onerous requirements on applicants, the agency was happy to cut its own paperwork.Read More
The move follows favorable product reception in the United Kingdom. Read More
The announcement comes as FDA Commissioner Robert Califf attempts to push past several controversies.Read More
A spokesperson for Juul Labs told Reuters that the company is looking at options to protect its business.Read More
Currently marketed Juul products must be removed from the U.S. market.Read More
But the FDA denied authorization to several other 'Daily' products. Read More
An extension on the deadline is not expected.Read More
The marketing orders cover NJOY’s Ace device and three tobacco-flavored liquid pods. Read More
